Boston Scientific Corp. vs. Beyond Air, Inc. Common Stock
Boston Scientific Corp. (BSX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BSX | XAIR | |
|---|---|---|
| Market Cap | $67.88 billion | $4.41 million |
| Revenue (TTM) | $21.00 billion | $7.69 million |
| Net Income (TTM) | $3.67 billion | $-34,410,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | XAIR | |
|---|---|---|
| P/E Ratio | 18.96 | — |
| Price / Book | 2.70 | 1.55 |
| Price / Sales | 3.23 | 0.57 |
XAIR leads on 2 of 2 valuation factors.
Profitability
| BSX | XAIR | |
|---|---|---|
| Net Margin | 17.47% | -447.64% |
| Return on Equity | 14.57% | -1212.05% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | XAIR | |
|---|---|---|
| Short Interest | 0.72% | 5.73% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, XAIR overview, XAIR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.